Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Clinical Research Products Management Center (CRPMC)

Closed
75N93026R00003Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Clinical Research Products Management Center (CRPMC) solicitation, identified as 75N93026R00003, is a competitive procurement issued by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services, with a due date of June 5, 2026. The contract aims to secure comprehensive clinical research product management services, including packaging, labeling, storage, and distribution of study materials in strict compliance with Good Distribution Practices, Good Clinical Practice, and current Good Manufacturing Practices. The scope encompasses operating and supporting the CRPMC Online Site Management and Ordering System (COSMOS), managing inventory, ensuring regulatory compliance, and delivering technical and progress reports via electronic systems. Offerors must respond with two separate, self-contained, word-searchable PDF volumes—one for the Technical Proposal and one for the Business Proposal—along with an unmodified Excel spreadsheet detailing cost estimates and fees. Proposals must be submitted electronically by the deadline, adhere to strict naming conventions, and exclude hyperlinks or external references. The contract is structured as a cost-reimbursement, indefinite-delivery/indefinite-quantity (IDIQ) type with a base period of one year and up to six one-year option periods, extending through March 2034. Performance is required at the NIH campus in Bethesda, Maryland, with final inspection and acceptance occurring at the Pharmaceutical Affairs Branch. The evaluation process prioritizes Technical Merit at 45% weighting, followed by Cost and Past Performance, with a best-value trade-off approach used for award; cost is not the determining factor, and the government explicitly states that non-cost factors collectively outweigh cost in decision-making. Special requirements include prohibitions on human subject research, human cloning, gene-editing of embryos, and use of funds for conferences or food. Offerors must have an active Unique Entity Identifier in SAM, certify size status under NAICS code 541715, and submit a Small Business Subcontracting Plan with goals totaling 32% for small businesses, including specific targets for disadvantaged, women-owned, HUBZone, and veteran-owned firms. All proposals are subject to review under FAR clauses addressing data rights, stop-work orders, fidelity bonds, prompt payment, contractor ethics, and electronic invoicing through the Treasury’s IPP system. The contract further mandates compliance with Section 508 accessibility standards, prohibits dissemination of misinformation, bans gun control advocacy, requires blocking of

General Info

Provide comprehensive clinical research product management services for NIH from 2027-2034 with regulatory compliance.

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

MD, USA

Set-Aside

NONE

Documents

3

Amendment 1 to RFP 75N93026R00003 Clinical Research Products Management Center

PDF, High priority: read this firstamendment
High

Amendment 2 to RFP 75N93026R00003 Clinical Research Products Management Center

PDF, High priority: read this firstamendment
High

RFP+75N93026R00003+w+attachments.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseClosed
Posted

Sources Sought

Type Changed

Sources Sought → Presolicitation

Type Changed

Presolicitation → Solicitation

Notice updated

Response deadline changed from Jun 1, 2026 to Jun 5, 2026. The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more

See attached Solicitation. 


See Amendment #1 attached. 


See Amendment #2 attached. 

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 811210
New
Federal
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC)
Solicitation # NOI-NIAID-27-2279300
The National Institutes of Health NIAID intends to award a firm-fixed price sole source contract to Revvity Health Sciences, Inc. for a one-year maintenance and service agreement for two Revvity Celigo S imaging instruments. The period of performance is scheduled from November 15, 2026, through November 14, 2027. This procurement is categorized under NAICS code 811210 for electronic and precision equipment repair and maintenance. The government is utilizing statutory authority 41 U.S.C. 3304(a)(1) and FAR 6.302.1(b)(1)(i), asserting that Revvity Health Sciences is the only responsible source capable of satisfying the requirement due to their proprietary access to diagnostic tools, service documentation, and genuine replacement parts. The scope of work includes priority response for unlimited repair travel, labor, and parts, as well as remote support and minor hardware and software updates to ensure the instruments meet manufacturer specifications. While the government intends to negotiate directly with the OEM, interested qualified sources were invited to submit capability statements by November 4, 2026, to the contracting officer, Linda Smith, and acquisition specialist, Jessica Emerson. The final award is expected to be issued within five days of the notice closing.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 7 days
View Details
NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

19 days ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS